Entry-into-humans study with ACT-462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexant
Article first published online: 21 APR 2014
© 2014, The American College of Clinical Pharmacology
The Journal of Clinical Pharmacology
Volume 54, Issue 9, pages 979–986, September 2014
How to Cite
Hoch, M., van Gorsel, H., van Gerven, J. and Dingemanse, J. (2014), Entry-into-humans study with ACT-462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexant. Journal of Clinical Pharma, 54: 979–986. doi: 10.1002/jcph.297
- Issue published online: 5 AUG 2014
- Article first published online: 21 APR 2014
- Accepted manuscript online: 1 APR 2014 06:46AM EST
- Manuscript Accepted: 27 MAR 2014
- Manuscript Received: 4 FEB 2014
- Actelion Pharmaceuticals Ltd
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!